GO
Loading...

Allergan Inc

More

  • Final Glance: Medical Devices companies Friday, 21 Nov 2014 | 6:02 PM ET

    Allergan fell $1.11 or. 5 percent, to $209.09. Baxter International Inc. rose$. 45 or. 6 percent, to $72.44. Boston Scientific Corp. fell$. 01 or. 1 percent, to $12.94.

  • Goldman Sachs Group Inc retained its No. 1 position as M&A adviser with deals worth $877 billion, followed by JPMorgan Chase& Co with $651 billion and Citigroup Inc with $633 billion. The $66.4 billion bid for Allergan Inc by Actavis PLC this week more than doubled the total value of deals in the healthcare sector to $364 billion. Halliburton Co's plans to buy...

  • Early Glance: Medical Devices companies Friday, 21 Nov 2014 | 10:17 AM ET

    Allergan rose$. 33 or. 2 percent, to $210.53. Baxter International Inc. rose$. 74 or 1.0 percent, to $72.73. Boston Scientific Corp. rose$. 13 or 1.0 percent, to $13.08.

  • CEOs in 10 big mergers to get $430M: Study Friday, 21 Nov 2014 | 8:20 AM ET
    David Pyott

    CEOs who decided to sell in the 10 biggest U.S. deals this year will rake in $430 million in "golden parachute" payments, according to a study.

  • Valeant slashes stake in Allergan after losing bid Thursday, 20 Nov 2014 | 7:14 PM ET

    Nov 20- Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker. Pershing Square Capital Management informed Valeant that PS Fund 1 sold all of its 2.2 million shares in Allergan allocated to Valeant USA, Valeant said in a regulatory filing.

  • Final Glance: Medical Devices companies Thursday, 20 Nov 2014 | 6:02 PM ET

    Allergan fell $2.39 or 1.1 percent, to $210.20. Baxter International Inc. fell$. 47 or. 6 percent, to $71.99. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.95.

  • Family gets $6.75 million in Botox treatment case Thursday, 20 Nov 2014 | 3:41 PM ET

    The verdict, in U.S. District Court in Burlington, came three days after the announcement that Parsippany, New Jersey- based drugmaker Actavis would acquire Botox maker Allergan for $66 billion, one of the biggest acquisitions announced this year. Thursday's verdict came four years after Irvine, California- based Allergan agreed to pay $600 million, pleading...

  • Midday Glance: Medical Devices companies Thursday, 20 Nov 2014 | 2:49 PM ET

    Allergan fell $2.09 or 1.0 percent, to $210.50. Baxter International Inc. fell$. 72 or 1.0 percent, to $71.74. Boston Scientific Corp. fell$. 18 or 1.4 percent, to $12.91.

  • Nov 20- Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it bought back no securities. The announcement comes a few days after acquisition-hungry Valeant's $54 billion offer to buy Botox maker Allergan Inc was trumped by Actavis Plc's $66...

  • Early Glance: Medical Devices companies Thursday, 20 Nov 2014 | 10:29 AM ET

    Allergan fell$. 52 or. 2 percent, to $212.07. Baxter International Inc. fell$. 54 or. 7 percent, to $71.92. Boston Scientific Corp. fell$. 16 or 1.3 percent, to $12.93.

  • Final Glance: Medical Devices companies Wednesday, 19 Nov 2014 | 6:02 PM ET

    Allergan fell$. 78 or. 4 percent, to $212.59. Baxter International Inc. fell$. 12 or. 2 percent, to $72.46. Boston Scientific Corp. fell$. 59 or 4.3 percent, to $13.09.

  • Midday Glance: Medical Devices companies Wednesday, 19 Nov 2014 | 1:31 PM ET

    Allergan rose$. 20 or. 1 percent, to $213.57. Baxter International Inc. fell$. 12 or. 2 percent, to $72.46. Boston Scientific Corp. fell$. 42 or 3.1 percent, to $13.26.

  • Early Glance: Medical Devices companies Wednesday, 19 Nov 2014 | 12:01 PM ET

    Allergan fell $1.37 or. 6 percent, to $212.00. Baxter International Inc. fell$. 02 or percent, to $72.56. Boston Scientific Corp. fell$. 14 or 1.0 percent, to $13.54.

  • *Nikkei erases gains, Asia shares hit by weak commodity prices. TOKYO, Nov 19- Japanese shares gave up early gains on Wednesday as investors booked profits after Prime Minister Shinzo Abe delayed a tax hike and said he would call a snap election to seek a fresh mandate for his economic policies. Japan's Nikkei erased earlier gains to stand flat by midday, showing...

  • TOKYO, Nov 19- Japanese stocks rose on Wednesday as investors held out hope for more robust growth after Prime Minister Shinzo Abe delayed a tax hike and called an early election to seek a fresh mandate for his aggressive policies to shore up the economy. MSCI's broadest index of Asia-Pacific shares outside Japan was a touch lower while Japan's Nikkei rose 0.6...

  • Cramer Remix: Warning to the skeptics Tuesday, 18 Nov 2014 | 7:32 PM ET

    "Mad Money" host Jim Cramer issues a warning investors should heed.

  • Cramer: Forget the long game, for now Tuesday, 18 Nov 2014 | 6:11 PM ET

    Jim Cramer just can't make sense of what's happening in the market. Why does it keep going higher? Is it time to stop questioning and jump in?

  • Final Glance: Medical Devices companies Tuesday, 18 Nov 2014 | 6:02 PM ET

    Allergan rose $4.22 or 2.0 percent, to $213.37. Baxter International Inc. rose$. 58 or. 8 percent, to $72.58. Boston Scientific Corp. rose$. 30 or 2.2 percent, to $13.68.

  • S&P, Dow end at record highs as global worries ease Tuesday, 18 Nov 2014 | 4:52 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Stocks rose on Tuesday, lifting the Dow and S&P 500 to their loftiest ever.

  • Actavis Plc, Gilead Sciences and other biotechs were among the biggest drivers, a day after Allergan agreed to be bought by Actavis. Shares of Actavis were up 8.7 percent at $269.60, helped by bullish analyst notes, while Gilead's stock rose 3.3 percent to $103.71 percent. "A little bit of a risk trade is coming back on, and those are the areas for the M&A," said Uri...